par Moor, Catharina C;Wijsenbeek, Marlies S;Balestro, Elisabetta;Biondini, Davide;Bondue, Benjamin 
;Cottin, Vincent;Flewett, Ron;Galvin, Liam;Jones, Steve;Molina-Molina, Maria;Planas-Cerezales, Lurdes;Prasse, Antje;Prosch, Helmut;Russell, Anne-Marie;Viegas, Michel;Wanke, Guenther;Wuyts, Wim;Kreuter, Michael;Bonella, Francesco
Référence ERJ Open Research, 5, 4
Publication Publié, 2019-10-01
;Cottin, Vincent;Flewett, Ron;Galvin, Liam;Jones, Steve;Molina-Molina, Maria;Planas-Cerezales, Lurdes;Prasse, Antje;Prosch, Helmut;Russell, Anne-Marie;Viegas, Michel;Wanke, Guenther;Wuyts, Wim;Kreuter, Michael;Bonella, FrancescoRéférence ERJ Open Research, 5, 4
Publication Publié, 2019-10-01
Article révisé par les pairs
| Résumé : | Pulmonary fibrosis (PF) and its most common form, idiopathic pulmonary fibrosis (IPF), are chronic, progressive diseases resulting in increasing loss of lung function and impaired quality of life and survival. The aim of this joint expert and patient statement was to highlight the most pressing common unmet needs of patients with PF/IPF, putting forward recommendations to improve the quality of life and health outcomes throughout the patient journey. |
